Prophecies of Doom: The Biotech Industry "Braces for Trump 2.0"!
But they are confident Marty Makary will help by diverting attention away from the biopharma side of the FDA.
I read the Endpoints News, a Financial Times subsidiary for bio-pharma news. It is sometimes useful to read the establishment perspective on what’s going on. Recently, they published an opinion piece by the Chief Editor and founder of Endpoints, John Carroll: The Endpoints 100: The biotech industry braces for Trump 2.0.
In the opening statement, John…
Keep reading with a 7-day free trial
Subscribe to Due Diligence and Art to keep reading this post and get 7 days of free access to the full post archives.